GFAP is an astrocyte intermediate filament protein that is thought to be a specific marker of astrocyte activation and/or injury after exposure to neurotoxic factors or other neurologic diseases (Yang et al
NAD+ and Sermorelin address different biological systems
The FGF family consists of 22 genes in the human genome
obviously each of these has very different business models (for example, DRI and CMG are almost completely company owned, while WING is almost exclusively franchised) and are at different places in their growth life cycle, so each deserves slightly (or massively!) different multiples and valuations, but, across the board, these multiples seem pretty rich even in a vacuum
This means that nerve cells in the brain are not working well
Gene expression studies using large-scale genomic databases have found that GHK-Cu is associated with the modulation of more than 4,000 human genes, a scale of interaction that researchers cite as evidence of the peptides broad regulatory reach at the cellular level
